D
MoonLake Immunotherapeutics MLTX
$39.65 $0.982.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Very Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Fair
Volatility Index Weak
Beta / Standard Deviation MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.61
Price History MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 4.25%
30-Day Total Return -9.16%
60-Day Total Return -29.57%
90-Day Total Return -14.55%
Year to Date Total Return -25.98%
1-Year Total Return -18.35%
2-Year Total Return 85.98%
3-Year Total Return 298.89%
5-Year Total Return --
52-Week High % Change -33.63%
52-Week Low % Change 5.89%
Price MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $58.26
52-Week Low Price $36.52
52-Week Low Price (Date) Mar 11, 2025
52-Week High Price (Date) Dec 17, 2024
Valuation MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 2.45B
Enterprise Value 2.01B
Price/Earnings (TTM) --
Earnings Per Share (TTM) -1.89
Earnings Per Share Growth 147.85%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 5.46
Enterprise Value/Revenue (TTM) --
Price $39.65
Enterprise Value/EBITDA (TTM) -14.17
Enterprise Value/EBIT -14.04
Market Cap Category Mid Cap
Dividends and Shares MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 63.07M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 41 415108022
Address --
Website www.moonlaketx.com
Country Switzerland
Year Founded 2021
Profitability MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -17.81%
Return on Equity --
Income Statement MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -141.71M
EBIT (TTM) -143.09M
Net Income (TTM) -118.94M
Net Income Avl. to Common (TTM) -118.94M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -488.23%
EPS Diluted (TTM) -1.89
EPS Diluted Growth (Q YOY) -482.68%
Balance Sheet MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 448.03M
Cash Per Share (Q) $7.10
Total Current Assets (Q) 474.29M
Total Preferred Equity (Q) --
Total Equity (Q) 453.39M
Current Ratio (Q) 21.113
Book Value Per Share (Q) $7.08
Total Assets (Q) 477.93M
Total Current Liabilities (Q) 22.46M
Total Debt (Q) 2.83M
Total Liabilities (Q) 24.54M
Total Common Equity (Q) 446.83M
Cash Flow MLTX - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -205.60M
Cash from Financing (TTM) 51.31M
Net Change in Cash (TTM) -270.74M
Levered Free Cash Flow (TTM) -92.06M
Cash from Operations (TTM) -116.59M
Weiss Ratings